ArticleCureus2025
Prevalence and Factors Associated With Dyslipidemia Among Adults With Type 2 Diabetes: Insights From the National Health and Nutrition Examination Survey (NHANES) 2009-2018.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Lipid Signatures Associated with Diabetic Peripheral Neuropathy in Obesity and Type 2 Diabetes-A Systematic Review.Journal of clinical medicine · 2026Review
- CABIT: a novel biomarkers-integrated inflammatory risk tool for ischemic heart disease developed in the USA and prospectively validated in China.Journal of translational medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objective Dyslipidemia is an atherogenic comorbidity common in type 2 diabetes and a major driver of cardiovascular events. This study aimed to examine the prevalence and factors associated with dyslipidemia (sociodemographic and clinical, such as waist circumference, blood pressure, smoking, BMI, and medication status) among U.S. adults with type 2 diabetes based on nationally representative data from the National Health and Nutrition Examination Survey (NHANES) 2009-2018. Methods We conducted a cross-sectional analysis of pooled NHANES 2009-2018, including adults aged ≥20 years with type 2 diabetes (n = 14,885; weighted N = 143,669,987). Dyslipidemia was defined by standard lipid thresholds. Survey weights, clusters, and strata were used; survey-adjusted t-tests and Rao-Scott F-tests were employed to compare groups. Multivariable survey logistic regression was utilized to estimate adjusted odds ratios (aOR) for key sociodemographic and clinical factors. Results Dyslipidemia was highly prevalent among adults with type 2 diabetes. Adjusted models showed older age (aOR per year: 1.01; p<0.001), female sex (aOR: 1.61; 95% confidence interval (CI): 1.44-1.79), greater waist circumference (aOR per cm: 1.03; 95% CI: 1.02-1.03), higher diastolic blood pressure (BP) (aOR per mmHg: 1.02; 95% CI: 1.01-1.02), and current smoking (aOR 1.34; 95% CI 1.17-1.53) were associated with higher odds. BMI and systolic BP were not significant. Non-Hispanic White and Non-Hispanic Black adults had lower adjusted odds than Mexican Americans. Conclusions Dyslipidemia remains a common comorbidity in adults with type 2 diabetes, shaped by both biological and social factors. Targeted, multidimensional interventions are required to address these disparities and reduce cardiovascular risk in this vulnerable population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.